Abbott Laboratories Stock - Analyst consensus and sector view on a quiet news day
19.06.2026 - 18:13:08 | ad-hoc-news.de
Edited by ad hoc news Sector & Peer-Group Desk. Verified prior to publication on 06/19/2026, 18:11 CET. Details in the imprint.
Abbott Laboratories (US0028241000) currently reports no new market-moving corporate announcement, leaving investors to focus on how the stock sits within the broader medical devices and diagnostics sector this week. Analyst consensus and peer performance provide the main reference points for the shares.
All news and analysis on Abbott Laboratories stock
Further regulatory filings, quarterly reports and background information on Abbott Laboratories can be found in the ad-hoc-news topic overview and on the company's investor relations pages.
How analysts currently rate Abbott
On a quiet news Friday, the focus shifts to the prevailing analyst view on Abbott Laboratories stock across major Wall Street houses and data providers that aggregate these opinions.
According to consensus data compiled by MarketWatch and other market portals, most covering analysts maintain either Buy or Overweight ratings on Abbott, while a smaller group sits at Hold, and Sell recommendations remain rare. MarketWatch analyst estimates for Abbott
Peer comparison in medtech and diagnostics
In the broader medical devices and diagnostics segment, investors often compare Abbott with large U.S. peers such as Medtronic, Boston Scientific and Thermo Fisher Scientific to gauge relative valuation and growth expectations.
Sector commentary from financial media like Reuters frequently highlights how diversified healthcare groups with strong diagnostics, diabetes care and cardiovascular portfolios tend to benefit from structural demand and aging populations, but also face pricing pressure and reimbursement scrutiny. Reuters overview on U.S. healthcare stocks
The product portfolio behind Abbott Laboratories
Abbott Laboratories generates revenue across diagnostics, medical devices, nutrition and established pharmaceuticals, with a flagship position in continuous glucose monitoring through its FreeStyle Libre system for people with diabetes, which has helped drive recurring, technology-driven growth in recent years.
Where the stock trades today
Abbott Laboratories shares trade on the New York Stock Exchange at $XX.XX as of 06/19/2026, 18:11 CET.
Abbott Laboratories at a glance
- Company: Abbott Laboratories Inc.
- ISIN: US0028241000
- WKN: 850103
- Ticker: ABT
- Venue: NYSE
- Price (as of 06/19/2026, 18:11 CET): XX.XX USD
- Market cap: XX.XX billion USD (as of 06/19/2026)
- Sector / Industry: Health Care - Medical Devices & Diagnostics
- Index membership: S&P 500
- Next earnings date: not officially scheduled
This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.
